Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. The annual global incidence is approximately 1 million cases, with a male to female ratio of approximately 4:1 (1:1 without cirrhosis to 9:1 in many high-incidence countries). The incidence rate equals the death rate. In the United States, approximately 22,000 new cases are diagnosed annually, with 18,000 deaths. The death rates in males in low-incidence countries such as the United States are 1.9 per 100,000 per year; in intermediate areas such as Austria and South Africa, they range from 5.1–20; and in high-incidence areas such as in the Orient (China and Korea) as high as 23.1–150 per 100,000 per year (Table 92–1). The incidence of HCC in the United States is approximately 3 per 100,000 persons, with significant gender, ethnic, and geographic variations. These numbers are rapidly increasing and may be an underestimate. Approximately 4 million chronic hepatitis C virus (HCV) carriers are in the United States alone. Approximately 10% of them or 400,000 are likely to develop cirrhosis. Approximately 5% or 20,000 of these may develop HCC annually. Add to this the two other common predisposing factors—hepatitis B virus (HBV) and chronic alcohol consumption—and 60,000 new HCC cases annually seem possible. Future advances in HCC survival will likely depend in part on immunization strategies for HBV (and HCV) and earlier diagnosis by screening of patients at risk of HCC development.
Table 92–1 Age-Adjusted Incidence Rates for Hepatocellular Carcinoma |Favorite Table|Download (.pdf)
Table 92–1 Age-Adjusted Incidence Rates for Hepatocellular Carcinoma
|Persons per 100,000 per Year|
|Brazil, Sao Paulo||3.8||2.6|
|South Africa, Cape: Black||26.3||8.4|
|South Africa, Cape: White||1.2||0.6|
With the U.S. HCV epidemic, HCC is increasing in most states, and obesity-associated liver disease (nonalcoholic steatohepatitis [NASH]) is increasingly recognized as a cause.
There are two general types of epidemiologic studies of HCC—those of country-based incidence rates (Table 92–1) and those of migrants. Endemic hot spots occur in areas of China and sub-Saharan Africa, which are associated both with high endemic hepatitis B carrier rates as well as mycotoxin contamination of foodstuffs (aflatoxin B1), stored grains, drinking water, and soil. Environmental factors are important, for example, Japanese in Japan have a higher incidence than those living in Hawaii, who in turn have a higher incidence than those living in California.